Pharmaceutical

Rafael Holdings and Cyclo Therapeutics enter merger deal

Rafael Holdings has signed a definitive merger agreement with Cyclo Therapeutics aiming to enhance the development of Trappsol Cyclo.

Aug 25, 2024 - 04:00
Rafael Holdings and Cyclo Therapeutics enter merger deal
Rafael Holdings has signed a definitive merger agreement with Cyclo Therapeutics aiming to enhance the development of Trappsol Cyclo.
Read the original article

Tags:

Previous Article

A comprehensive guide to supply chain management for specialty drugs

Next Article

VION Biosciences acquires Echelon Biosciences

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Avadel Pharmaceuticals gets grant for patent granted for modified release formulation of gamma-hydroxybutyrate

Avadel Pharmaceuticals gets grant for patent granted fo...

Jun 8, 2024

Non-infectious Uveitis drugs in development, 2024

Aug 31, 2024

STAT+: Here are the worst biopharma CEOs of 2023

STAT+: Here are the worst biopharma CEOs of 2023

Dec 19, 2023